RFA-DK-22-002: Helping to Accelerate Research Potential (HARP) (UE5 - Clinical Trial Not Allowed)
Closed
This grant is closed. Who won this program's grants before is below, and similar open grants are at the end of the page. It is in our archive of National Institutes of Health notices from 2022.
National Institutes of Health offered grants of up to $150,000 to nonprofits, colleges and universities, state and local governments, tribes, small businesses and businesses. Applications closed on November 30, 2022.
From the official notice on Grants.gov, last changed July 28, 2022. Checked November 7, 2026.
- Award ceiling$150,000
- Cost sharingNot required
- Funding typeCooperative Agreement
About this NIH notice
- Activity codeUE5
- Clinical trialsNot allowed
- Funded byNIDDK
- Median yearly award$161,182
- Typical project length5 years
- UE5, Education Project Cooperative Agreement. Research education programs, with substantial NIH involvement. Other open UE5 notices.
Projects funded under RFA-DK-22-002 were run by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK, 5 projects). Contact the program officer at the institute that fits your project before you apply; the notice lists them.
Application due dates, page limits and budget limits are set in the notice. Read RFA-DK-22-002 in the NIH Guide.
Key dates
| Posted | July 28, 2022 |
|---|---|
| Deadline | November 30, 2022 |
| Archived by Grants.gov | January 5, 2023 |
Who can apply
This opportunity was open to nonprofits, colleges and universities, state and local governments, tribes, small businesses and businesses.
All 15 applicant types the notice lists
- State governments
- County governments
- City or township governments
- Special district governments
- Independent school districts
- Public and State controlled institutions of higher education
- Native American tribal governments (Federally recognized)
- Public housing authorities/Indian housing authorities
- Native American tribal organizations (other than Federally recognized tribal governments)
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
- Private institutions of higher education
- For profit organizations other than small businesses
- Small businesses
- Others (see text field entitled "Additional Information on Eligibility" for clarification)
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.
Is this a realistic fit?
- Projects NIH funded under this notice had a median yearly award of $161,182; it allows up to $150,000 per award.
- Most of the program's money (70% over five years) went to colleges and universities.
- No cost sharing or match is required.
What the grant funds
The purpose of this Funding Opportunity Announcement (FOA) is to support mentors who will develop educational activities and provide appropriate mentoring to NIDDK scholars and early career individuals from diverse backgrounds, including those from groups underrepresented in biomedical, behavioral, clinical, and social sciences research. The goal is to provide these scholars tailored mentoring so that they may advance and succeed in NIDDK-relevant, independent research careers. Mentoring has long served an essential role in developing a scientific workforce, and research shows that it is critical to supporting the careers of early career faculty from underrepresented backgrounds. Support would be provided to mentors who will develop educational activities and evidence-informed mentoring to a diverse cohort of scholars.
Funded under RFA-DK-22-002 so far
NIH funded 5 projects under RFA-DK-22-002 in fiscal 2023 to 2026, at 5 institutions. The median yearly award was $161,182.
| Project | Institution | Fiscal year | Award |
|---|---|---|---|
| Empirically Based Career Development Program for Early Career Trainees Supported by NIDDK | University of California, San Francisco | 2026 | $157,942 |
| Medical University of South Carolina Mentoring Program in Digestive and Liver Diseases | Medical University of South Carolina | 2026 | $161,182 |
| Accelerating Research Advancement for Early Career Investigators in Academia | Massachusetts General Hospital | 2026 | $140,808 |
| Accelerating Early-Career Independent Research Potential in Nutrition Sciences | University of Alabama at Birmingham | 2026 | $161,894 |
| Workshops and Coaching to Foster Career Skills in Newly Funded NIDDK Scholars | University of Miami School of Medicine | 2026 | $162,000 |
Who has won Diabetes, Digestive, and Kidney Diseases Extramural Research grants before
From fiscal 2021 to 2025, Diabetes, Digestive, and Kidney Diseases Extramural Research (93.847) awarded $9.6 billion across 7,877 grant awards, an average of $1.2 million per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| Regents of the University of Michigan | Michigan | 273 | $345 million |
| The Trustees of the University of Pennsylvania | Pennsylvania | 187 | $272 million |
| University of Pittsburgh - of the Commonwealth System of Higher Education | Pennsylvania | 209 | $238 million |
| The Washington University | Missouri | 187 | $227 million |
| The Regents of the University of California, San Francisco | California | 176 | $208 million |
Applying now
This notice no longer takes applications. Agencies often post the same opportunity again under a new number, so check the program's notices on Grants.gov and the similar open grants below.
The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.
Questions people ask
Is RFA-DK-22-002 still open?
No. It closed on November 30, 2022.
Who can apply for Helping to Accelerate Research Potential (HARP) (UE5 - Clinical Trial Not Allowed)?
National Institutes of Health accepted applications from nonprofits, colleges and universities, state and local governments, tribes, small businesses and businesses. The notice adds further conditions, so read its eligibility section.
What is the deadline for Helping to Accelerate Research Potential (HARP) (UE5 - Clinical Trial Not Allowed)?
Closed November 30, 2022. Applications are no longer accepted; the program's newer notices are on this page when there are any.
How much funding is available?
Awards of up to $150,000 each.
Who has been funded under RFA-DK-22-002?
NIH RePORTER lists 5 projects funded under RFA-DK-22-002 in fiscal 2023 to 2026, at 5 institutions. The most were at University of California, San Francisco, Medical University of South Carolina, Massachusetts General Hospital.
Who has won Diabetes, Digestive, and Kidney Diseases Extramural Research grants before?
The largest recipients over five fiscal years were Regents of the University of Michigan, The Trustees of the University of Pennsylvania, University of Pittsburgh - of the Commonwealth System of Higher Education. The program made 7,877 awards worth $9.6 billion in that time.
Similar open grants
- Limited Competition: Supporting Programs to Advance Research Knowledge in Environmental Health Sciences (SPARK-EHS) (UE5/T32 - Clinical Trial Not Allowed)
- Tribal Undergraduate to Graduate Research Training and Leadership Experiences (TURTLE) Program (UE5/T32)
- Tribal Undergraduate to Graduate Research Training and Leadership Experiences (TURTLE) Program (UE5/T34)
- NIH Research Educational Program - Mentoring Activities & Networks (Parent R25/UE5 - Clinical Trial Not Allowed)
- Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required)
- Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)